Literature DB >> 1439717

[Various ultrasound methods for studying the vertebral artery--a comparative evaluation].

A Delcker1, H C Diener.   

Abstract

In a prospective study 451 patients were examined with extracranial continuous-wave (CW) Doppler sonography, transcranial Doppler sonography and color coded duplex sonography in order to evaluate the diagnostic accuracy of the three methods for vertebral artery pathology (hypoplasia, proximal and distal stenosis and occlusion). Color duplex sonography was used as the reference method. CW-Doppler sonography (mastoidal slope) had a sensitivity of 100% and a specificity of 27% for the detection of pathological changes in vertebral arteries (VA). For suboccipital transcranial Doppler sonography these values were 38% and 58%. Extracranial Doppler sonography and transcranial Doppler sonography are often unsuitable for differentiating between proximal stenosis and hypoplasia of VA. Transcranial Doppler sonography of the terminal segments of VA resulted in normal flow parameters in 27% of cases with proximal stenosis and in 50% in cases of proximal occlusion. Flow was normal in these particular cases owing to a more distal collateralisation of the VA. The terms "hypoplasia" and "asymmetric" of VA are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1439717     DOI: 10.1055/s-2007-1005313

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  2 in total

1.  Hypoplastic vertebral artery: frequency and associations with ischaemic stroke territory.

Authors:  Jong-Ho Park; Jeong-Min Kim; Jae-Kyu Roh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154

2.  Association between vertebral artery hypoplasia and posterior circulation stroke.

Authors:  Virginija Gaigalaite; Augenijus Vilimas; Violeta Ozeraitiene; Jurate Dementaviciene; Ricardas Janilionis; Danute Kalibatiene; Saulius Rocka
Journal:  BMC Neurol       Date:  2016-07-26       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.